TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
KROS

Keros Therapeutics Inc

Healthcare · Biotechnology

11.60$ +0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow KROS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– -327.2% – – – – – –
– +186.3% -36.5% +36.0% +78.3% +20.9% +50.8% +22.8%
– -27.2% +6,844.1% +186.1% +59.4% +54.0% +21.2% -17.7%
– +937.8% +107.2% +99.0% +58.9% – – –
– -184.6% – -806.4% – -118.5% – –
– +24.9% +8.5% +248.3% +21.2% +98.5% -21.6% -19.7%
– +24.9% +8.5% +248.3% +21.2% +98.5% -21.6% -19.7%
– -99.9% +2,135,707.1% -90.5% +321.4% – – –
– – – – – – – –
– -99.9% +2,114,500.0% -90.4% +321.4% +48.7% +118.9% -196.6%
– -188.8% – -113.4% – +6.1% +340.6% -219.0%
– -338.4% – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?